Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

1.11 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -56.584-33.97-63.344-53.088-16.703-26.587
Depreciation & Amortization 1.0280.8220.5480.4970.5890.564
Deferred Income Tax 0001.07100
Stock Based Compensation 16.03119.00815.78222.59500
Change In Working Capital 0-2.140.509-3.4291.044-0.163
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.711-0.5950.1630.5430.933-0.271
Other Working Capital -0.827-1.5450.346-3.9720.1110.108
Other Non Cash Items 4.029-34.956-0.010.1090.11-0.081
Operating Cash Flow -35.496-51.236-46.515-32.245-14.96-26.267
Investing Activities:
Investments In Property Plant And Equipment -0.268-1.229-1.619-0.506-1.2-1.581
Acquisitions Net 00-0.851000.049
Purchases Of Investments -58.72-73.261-73.817000
Sales Maturities Of Investments 77.55104.353000
Other Investing Activites 1.24700.851000
Investing Cash Flow 19.80929.86-72.436-0.506-1.2-1.532
Financing Activities:
Debt Repayment -5029.574-2.8484.1910
Common Stock Issued 18.2620.3950.31773.64871.2720
Common Stock Repurchased 0.304-0-0.001000
Dividends Paid 000000
Other Financing Activities 0.3230.233-0.56986.31468.4910.852
Financing Cash Flow 13.5850.23329.00577.14672.6820.852
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -2.102-21.143-89.94644.39556.522-26.947
Cash At End Of Period 4.2626.36427.507117.45373.05816.536